Risk stratification for colorectal cancer and implications for screening

被引:0
|
作者
Tejpar, S [1 ]
机构
[1] Katholieke Univ Leuven, Ctr Human Genet, Dept Internal Med, Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
来源
ACTA GASTRO-ENTEROLOGICA BELGICA | 2005年 / 68卷 / 02期
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In addition to the well-recognized syndromes described (FAP, HNPCC) clusters of colorectal cancers occur in families much more often than would be expected by chance. This familial clustering in about 10-20% of colorectal cancers has implications for screening because the immediate family members of a patient with apparent sporadic colorectal cancer have a twofold to threefold increased risk of the disease. The magnitude of the risk depends on the age at diagnosis of the index case, the degree of kinship of the index case to the at-risk case, and the number of affected relatives. In addition to screening the easily identifiable high-risk groups such as FAP and HNPCC, care should be taken to recognize intermediate-risk patients and to provide them with appropriate screening recommendations. Because the molecular basis and the natural history of these intermediate-risk patients are largely unknown, screening recommendations are as yet more empirical. If a person has a first degree relative with colon cancer, average risk colon cancer screening is recommended, but starting at age 40 years. The decreased age is given because the risk at age 40 for those with an affected first-degree relative is similar to the risk at age 50 for the general population. An individual with two first-degree relatives affected with colon cancer or one first-degree relative diagnosed under the age of 60 y should have colonoscopy beginning at age 40, or 10 years younger than the earliest case in the family. Colonoscopy should be repeated every five years if negative. An even stronger family history of colon cancer syndromes of colon cancer should suggest the consideration of one of the inherited syndromes..
引用
收藏
页码:241 / 242
页数:2
相关论文
共 50 条
  • [41] Histopathologic risk stratification of stage IIB colorectal cancer
    Komori, Koji
    Kinoshita, Takashi
    Oshiro, Taihei
    Ito, Seiji
    Abe, Tetsuya
    Senda, Yoshiki
    Misawa, Kazunari
    Ito, Yuichi
    Uemura, Norihisa
    Natsume, Seiji
    Kawakami, Jiro
    Ouchi, Akira
    Tsutsuyama, Masayuki
    Hosoi, Takahiro
    Shigeyoshi, Itaru
    Akazawa, Tomoyuk
    Hayashi, Daisuke
    Tanaka, Hideharu
    Shimizu, Yasuhiro
    SURGERY TODAY, 2017, 47 (08) : 934 - 939
  • [42] Histopathologic risk stratification of stage IIB colorectal cancer
    Koji Komori
    Takashi Kinoshita
    Taihei Oshiro
    Seiji Ito
    Tetsuya Abe
    Yoshiki Senda
    Kazunari Misawa
    Yuichi Ito
    Norihisa Uemura
    Seiji Natsume
    Jiro Kawakami
    Akira Ouchi
    Masayuki Tsutsuyama
    Takahiro Hosoi
    Itaru Shigeyoshi
    Tomoyuk Akazawa
    Daisuke Hayashi
    Hideharu Tanaka
    Yasuhiro Shimizu
    Surgery Today, 2017, 47 : 934 - 939
  • [43] RISK AND SCREENING FOR COLORECTAL-CANCER
    WINAWER, SJ
    MILLER, DG
    SHERLOCK, P
    ADVANCES IN INTERNAL MEDICINE, 1984, 30 : 471 - 496
  • [44] Molecular classification and risk stratification of colorectal cancer.
    Inoue, Yoshikage
    Kakiuchi, Nobuyuki
    Yoshida, Kenichi
    Nanya, Yasuhito
    Takeuchi, Yasuhide
    Fujii, Yoichi
    Shiraishi, Yuichi
    Chiba, Kenichi
    Nagayama, Satoshi
    Obama, Kazutaka
    Ogawa, Seishi
    CANCER RESEARCH, 2022, 82 (12)
  • [45] Colorectal cancer risk stratification in a community gastroenterology practice
    McKibbin, Ralph
    Mazzei, Bonita
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S541 - S541
  • [46] Interval cancer risk after the upper age limit of screening has been reached: Informing risk stratification in FIT-based colorectal cancer screening
    van Stigt, Brenda J.
    Lansdorp-Vogelaar, Iris
    Spaander, Manon C. W.
    van Vuuren, Anneke J.
    Dekker, Evelien
    van Kemenade, Folkert J.
    Nagtegaal, Iris D.
    van Leerdam, Monique E.
    Toes-Zoutendijk, Esther
    INTERNATIONAL JOURNAL OF CANCER, 2025, 156 (09) : 1783 - 1790
  • [47] An immunogenomic stratification of colorectal cancer: Implications for development of targeted immunotherapy
    Lal, Neeraj
    Beggs, Andrew D.
    Willcox, Benjamin E.
    Middleton, Gary W.
    ONCOIMMUNOLOGY, 2015, 4 (03): : 1 - 9
  • [48] Inappropriate colorectal cancer screening: Findings and implications
    Fisher, DA
    Judd, L
    Sanford, NS
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (11): : 2526 - 2530
  • [49] Risk stratification for advanced proximal colon neoplasm and individualized endoscopic screening for colorectal cancer by a risk-scoring model
    Park, Hye Won
    Han, Seungbong
    Lee, Jong-Soo
    Chang, Hye-Sook
    Lee, Don
    Choe, Jae-Won
    Myung, Seung-Jae
    Yang, Suk-Kyun
    Kim, Jin-Ho
    Byeon, Jeong-Sik
    GASTROINTESTINAL ENDOSCOPY, 2012, 76 (04) : 818 - 828
  • [50] Whole-blood DNA Methylation Markers for Risk Stratification in Colorectal Cancer Screening: A Systematic Review
    Raut, Janhavi R.
    Guan, Zhong
    Schrotz-King, Petra
    Brenner, Hermann
    CANCERS, 2019, 11 (07)